Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson Disease”

259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 259 results

Large-scale testing (Phase 3)Looking for participantsNCT07174310
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 900
Post-approval studies (Phase 4)Study completedNCT01673724
What this trial is testing

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sandoz 121
Not applicableUnknownNCT01338662
What this trial is testing

Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

Who this might be right for
Parkinson's Disease
Seoul National University Hospital 500
Not applicableStudy completedNCT01470859
What this trial is testing

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Huashan Hospital 30
Post-approval studies (Phase 4)Ended earlyNCT01048229
What this trial is testing

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
Qualissima 112
Testing effectiveness (Phase 2)Study completedNCT00407212
What this trial is testing

Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Who this might be right for
Parkinson's Disease
Novartis 301
Large-scale testing (Phase 3)Study completedNCT00594165
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Who this might be right for
Early-Stage Parkinson's Disease
UCB Pharma 217
Large-scale testing (Phase 3)Study completedNCT03568968
What this trial is testing

Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Haukeland University Hospital 410
Not applicableStudy completedNCT03043768
What this trial is testing

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
GWT-TUD GmbH 50
Not applicableLooking for participantsNCT06688968
What this trial is testing

Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Early OnsetParkinsons Disease with DementiaNon Pharmacological Intervention
University Hospital, Montpellier 120
Not applicableStudy completedNCT02403765
What this trial is testing

Diagnostic Tools for Parkinson's Disease

Who this might be right for
Parkinson Disease
Neuromed IRCCS 500
Not applicableStudy completedNCT01380899
What this trial is testing

Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Universidad Autonoma de San Luis Potosí 87
Large-scale testing (Phase 3)Study completedNCT00256204
What this trial is testing

Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 1,174
Not applicableEnded earlyNCT03716258
What this trial is testing

Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)

Who this might be right for
Parkinson DiseaseMovement Disorders
Oregon Health and Science University 16
Not applicableStudy completedNCT04114318
What this trial is testing

The Role of Cycling-cognitive Dual-task Training in Early Parkinson's Disease

Who this might be right for
Safety and Effectiveness
Chang Gung Memorial Hospital 26
Large-scale testing (Phase 3)Ended earlyNCT01929317
What this trial is testing

Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Who this might be right for
Parkinson Disease
GlaxoSmithKline 81
Large-scale testing (Phase 3)Study completedNCT02864004
What this trial is testing

Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

Who this might be right for
Parkinson's Disease
Rennes University Hospital 134
Testing effectiveness (Phase 2)Study completedNCT02939391
What this trial is testing

KW-6356 in Subjects With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 175
Large-scale testing (Phase 3)UnknownNCT03594656
What this trial is testing

Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Xuanwu Hospital, Beijing 288
Not applicableUnknownNCT05640986
What this trial is testing

Use of BART Coupled With EEG in the Early Diagnosis of Behavioral Disorders in Parkinson's Disease

Who this might be right for
Parkinson Disease
Centre Hospitalier Universitaire de Besancon 80
Next Page